Viewing Study NCT00698100


Ignite Creation Date: 2025-12-26 @ 12:17 PM
Ignite Modification Date: 2026-01-13 @ 10:38 AM
Study NCT ID: NCT00698100
Status: COMPLETED
Last Update Posted: 2011-09-16
First Post: 2008-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Skin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DNA View
None HU & MOUSE View
None TYROSINASE View